Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

New treatments are being explored to slow or reverse hereditary hair loss.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

CEC levels may be a useful marker for predicting prostate cancer progression.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Androgenetic alopecia is common hair loss caused by genetics and hormones.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

Lowering testosterone speeds up wound healing in male mice.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.